Search company, investor...

Sun-Novo Pharmaceutical

sun-novo.com

Founded Year

2009

Stage

IPO | IPO

Date of IPO

6/21/2021

About Sun-Novo Pharmaceutical

Sun-Novo Pharmaceutical (688621.SH) is a CRO companies (Contract Research Organization) that provided drug R&D services

Headquarters Location

1st Floor, Building 7, No. 79 Shuangying West Road Science and Technology Park, Changping District

Beijing, Beijing,

China

Missing: Sun-Novo Pharmaceutical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Sun-Novo Pharmaceutical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Sun-Novo Pharmaceutical News

© S&P Capital IQ 2022 All news about BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD. 10/25 Beijing Sun-Novo Pharmaceutical Research Co., Ltd. agreed to acquire an unknown minority stake in Beijing Langyan Life Technology Holdings Co., Ltd. from Li Qian, Ganzhou Langyi Investment Center (Limited Partnership) and Liu Yujing

Nov 8, 2022

10/24 08/09 10/25/2022 EST Message : *Required fields Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHSE:688621) agreed to acquire an unknown minority stake in Beijing Langyan Life Technology Holdings Co., Ltd. from Li Qian, Ganzhou Langyi Investment Center (Limited Partnership) and Liu Yujing on October 25, 2022. Under the terms, consideration will be paid in form of cash and shares.

Sun-Novo Pharmaceutical Frequently Asked Questions (FAQ)

  • When was Sun-Novo Pharmaceutical founded?

    Sun-Novo Pharmaceutical was founded in 2009.

  • Where is Sun-Novo Pharmaceutical's headquarters?

    Sun-Novo Pharmaceutical's headquarters is located at 1st Floor, Building 7, No. 79 Shuangying West Road, Beijing.

  • What is Sun-Novo Pharmaceutical's latest funding round?

    Sun-Novo Pharmaceutical's latest funding round is IPO.

  • Who are the investors of Sun-Novo Pharmaceutical?

    Investors of Sun-Novo Pharmaceutical include Wuhan Investment, GF Xinde Investment Management Co., Haida Bicheng, GF Qianhe, Jingxiang Capital and 12 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.